The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis

被引:5
|
作者
Yan, Mengchao [1 ,2 ]
Xie, Ye [2 ,3 ]
Yao, Jia [2 ,3 ]
Li, Xun [1 ,2 ,3 ]
机构
[1] Lanzhou Univ, Hosp 1, Dept Gen Surg, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Sch Med, Lanzhou 730000, Peoples R China
[3] Key Lab Biotherapy & Regenerat Med Gansu Prov, Lanzhou 730000, Peoples R China
关键词
liver fibrosis; hepatic stellate cells; transforming growth factor beta; activation model; STEATOHEPATITIS;
D O I
10.3390/ijms242015460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatic stellate cells (HSCs) are the key promoters of liver fibrosis. In response to liver-fibrosis-inducing factors, HSCs express alpha smooth muscle actin (alpha-SMA) and obtain myofibroblast phenotype. Collagen secretion and high expression of alpha-SMA with related high cell tension and migration limitation are the main characteristics of myofibroblasts. How these two characteristics define the role of myofibroblasts in the initiation and progression of liver fibrosis is worth exploring. From this perspective, we explored the correlation between alpha-SMA expression and collagen secretion in myofibroblasts and the characteristics of collagen deposition in liver fibrosis. Based on a reasonable hypothesis and experimental verification, we believe that the myofibroblast with the alpha-SMAhighcollagenhigh model do not effectively explain the initial stage and progression characteristics of liver fibrosis. Therefore, we propose a myofibroblast dual-mode transition model in fibrotic liver (DMTM model). In the DMTM model, myofibroblasts have dual modes. Myofibroblasts obtain enhanced alpha-SMA expression, accompanied by collagen expression inhibition in the high-concentration region of TGF-beta. At the edge of the TGF-beta positive region, myofibroblasts convert to a high-migration and high-collagen secretion phenotype. This model reasonably explains collagen deposition and expansion in the initial stage of liver fibrosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Hepatic stellate cells and liver fibrosis
    Moreira, Roger Klein
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (11) : 1728 - 1734
  • [2] Hepatic Stellate Cells and Liver Fibrosis
    Puche, Juan E.
    Saiman, Yedidya
    Friedman, Scott L.
    COMPREHENSIVE PHYSIOLOGY, 2013, 3 (04) : 1473 - 1492
  • [3] Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
    Krenkel, Oliver
    Hundertmark, Jana
    Ritz, Thomas P.
    Weiskirchen, Ralf
    Tacke, Frank
    CELLS, 2019, 8 (05)
  • [4] Involvement of hepatic stellate cell-derived myofibroblasts and portal myofibroblasts in liver fibrosis: A comparative study using proteomics and transcriptomics
    Bosselut, N.
    Cadoret, A.
    Marcelo, P.
    Barbu, V.
    Rey, C.
    Guechot, J.
    Vinh, J.
    Housset, C.
    Vaubourdolle, M.
    Baudin, B.
    FEBS JOURNAL, 2010, 277 : 198 - 198
  • [5] Hepatic stellate cells from zone 1 do not transform into myofibroblasts but engage in capillarization in preclinical models of liver fibrosis
    Ashfaq-Khan, Muhammad
    Fischer, Julian
    Schwiering, Fabian
    Groneberg, Dieter
    Friebe, Andreas
    JOURNAL OF HEPATOLOGY, 2023, 78 : S330 - S331
  • [6] Spontaneously immortalized cell line from rat liver fibrosis with phenotypes of both hepatic stellate cells and myofibroblasts.
    Xiong, SG
    Yavrom, S
    Hazra, S
    Wu, DY
    She, H
    French, SW
    Ramadori, G
    Tsukamoto, H
    HEPATOLOGY, 2001, 34 (04) : 520A - 520A
  • [7] The role of hepatic stellate cells/myofibroblasts
    Pinzani, M
    PORTAL HYPERTENSION IN THE 21ST CENTURY, 2004, : 37 - 46
  • [8] BONE MARROW DERIVED MESENCHYMAL STROMAL CELLS DIFFER FROM HEPATIC STELLATE CELLS AND ATTENUATE LIVER FIBROSIS
    Chinnadurai, R.
    Galipeau, J.
    CYTOTHERAPY, 2015, 17 (06) : S35 - S35
  • [9] Wntless Loss from Hepatic Stellate Cells is Dispensable for Liver Fibrosis
    Zhang, R.
    Preziosi, M. E.
    Kikuchi, A. T.
    Poddar, M.
    Schwabe, R.
    Monga, S. P.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (10): : 2368 - 2368
  • [10] Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis
    Ling Wang
    Yinghao Wang
    Jun Quan
    Human Cell, 2020, 33 : 582 - 589